Self-sufficing H2O2-responsive nanocarriers through tumor-specific H2O2 production for synergistic...

Area of Science:

• Biomedical Engineering
• Nanomedicine
• Oncology

Background:

• Tumor tissues exhibit elevated reactive oxygen species (ROS), crucial for immortality, proliferation, and metastasis.
• Existing ROS-responsive materials face limitations due to insufficient endogenous ROS levels in tumors for effective activation.
• Tumor cells have a reduced capacity to eliminate harmful ROS, creating a unique microenvironment.

Purpose of the Study:

• To develop a self-sufficing nanomedicine platform that enhances tumor hydrogen peroxide (H2O2) levels to trigger drug release.
• To investigate the synergistic effects of oxidation and chemotherapy for enhanced tumor suppression.
• To overcome the limitations of current ROS-responsive systems in in vivo applications.

Main Methods:

• Formulation of a H2O2-responsive camptothecin (CPT) polymer prodrug micelle incorporating palmitoyl ascorbate (PA).
• PA was utilized as a prooxidant to generate H2O2 specifically within the tumor microenvironment.
• Evaluation of H2O2 production, CPT release, cellular uptake, synergistic cytotoxicity, and in vivo tumor suppression.

Main Results:

• The nanocarrier system successfully generated sustained H2O2 levels specifically in tumors.
• Elevated H2O2 induced tumor cell apoptosis and triggered CPT release for chemotherapy.
• The combination of excess H2O2 and released CPT demonstrated synergistic cytotoxicity, leading to potent tumor suppression in vivo.
• The developed nanomedicine platform achieved synergistic oxidation-chemotherapy.

Conclusions:

• This novel nanomedicine platform effectively up-regulates tumoral H2O2 levels, enabling self-sufficing, H2O2-responsive drug release.
• The synergistic combination of oxidation and chemotherapy offers a potent strategy for cancer treatment.
• This approach represents a promising advancement in nanomedicine for enhanced tumor suppression.